Literature DB >> 28663230

Tissue-Specific MicroRNA Expression Patterns in Four Types of Kidney Disease.

Maria Angeles Baker1, Seth J Davis1, Pengyuan Liu1, Xiaoqing Pan1, Anna Marie Williams1, Kenneth A Iczkowski2, Sean T Gallagher1, Kaylee Bishop1, Kevin R Regner3, Yong Liu1, Mingyu Liang4.   

Abstract

MicroRNAs contribute to the development of kidney disease. Previous analyses of microRNA expression in human kidneys, however, were limited by tissue heterogeneity or the inclusion of only one pathologic type. In this study, we used laser-capture microdissection to obtain glomeruli and proximal tubules from 98 human needle kidney biopsy specimens for microRNA expression analysis using deep sequencing. We analyzed specimens from patients with diabetic nephropathy (DN), FSGS, IgA nephropathy (IgAN), membranoproliferative GN (MPGN) (n=19-23 for each disease), and a control group (n=14). Compared with control glomeruli, DN, FSGS, IgAN, and MPGN glomeruli exhibited differential expression of 18, 12, two, and 17 known microRNAs, respectively. The expression of several microRNAs also differed between disease conditions. Specifically, compared with control or FSGS glomeruli, IgAN glomeruli exhibited downregulated expression of hsa-miR-3182. Furthermore, in combination, the expression levels of hsa-miR-146a-5p and hsa-miR-30a-5p distinguished DN from all other conditions except IgAN. Compared with control proximal tubules, DN, FSGS, IgAN, and MPGN proximal tubules had differential expression of 13, 14, eight, and eight microRNAs, respectively, but expression of microRNAs did not differ significantly between the disease conditions. The abundance of several microRNAs correlated with indexes of renal function. Finally, we validated the differential glomerular expression of select microRNAs in a second cohort of patients with DN (n=19) and FSGS (n=21). In conclusion, we identified tissue-specific microRNA expression patterns associated with several kidney pathologies. The identified microRNAs could be developed as biomarkers of kidney diseases and might be involved in disease mechanisms.
Copyright © 2017 by the American Society of Nephrology.

Entities:  

Keywords:  biopsy; chronic kidney disease; glomerulus; kidney; microRNA; proximal tubule

Mesh:

Substances:

Year:  2017        PMID: 28663230      PMCID: PMC5619963          DOI: 10.1681/ASN.2016121280

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  44 in total

1.  Breakthrough of the year. Small RNAs make big splash.

Authors:  Jennifer Couzin
Journal:  Science       Date:  2002-12-20       Impact factor: 47.728

Review 2.  The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.

Authors:  Alison J Kriegel; Yong Liu; Yi Fang; Xiaoqiang Ding; Mingyu Liang
Journal:  Physiol Genomics       Date:  2012-01-03       Impact factor: 3.107

3.  Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.

Authors:  Junnan Wu; Chunxia Zheng; Yun Fan; Caihong Zeng; Zhaohong Chen; Weisong Qin; Changming Zhang; Wanfen Zhang; Xiao Wang; Xiaodong Zhu; Mingchao Zhang; Ke Zen; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

4.  Integrative biology identifies shared transcriptional networks in CKD.

Authors:  Sebastian Martini; Viji Nair; Benjamin J Keller; Felix Eichinger; Jennifer J Hawkins; Ann Randolph; Carsten A Böger; Crystal A Gadegbeku; Caroline S Fox; Clemens D Cohen; Matthias Kretzler
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

5.  Thiol-related genes in diabetic complications: a novel protective role for endogenous thioredoxin 2.

Authors:  Mingyu Liang; Jennifer L Pietrusz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-10-26       Impact factor: 8.311

Review 6.  MicroRNAs in kidney physiology and disease.

Authors:  Piera Trionfini; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2014-11-11       Impact factor: 28.314

7.  Endogenous microRNAs in human microvascular endothelial cells regulate mRNAs encoded by hypertension-related genes.

Authors:  Alison J Kriegel; Maria Angeles Baker; Yong Liu; Pengyuan Liu; Allen W Cowley; Mingyu Liang
Journal:  Hypertension       Date:  2015-08-17       Impact factor: 10.190

8.  MiR-486-3p targeting ECM1 represses cell proliferation and metastasis in cervical cancer.

Authors:  Haiqiong Ye; Xiaolan Yu; Jiyi Xia; Xiaoping Tang; Li Tang; Feng Chen
Journal:  Biomed Pharmacother       Date:  2016-03-18       Impact factor: 6.529

9.  miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation.

Authors:  Yi Fang; Xiaofang Yu; Yong Liu; Alison J Kriegel; Yanyan Heng; Xialian Xu; Mingyu Liang; Xiaoqiang Ding
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-06

10.  A Review of Computational Tools in microRNA Discovery.

Authors:  Clarissa P C Gomes; Ji-Hoon Cho; Leroy Hood; Octávio L Franco; Rinaldo W Pereira; Kai Wang
Journal:  Front Genet       Date:  2013-05-15       Impact factor: 4.599

View more
  42 in total

Review 1.  Epigenetic Mechanisms and Hypertension.

Authors:  Mingyu Liang
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

Review 2.  Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

3.  Artificial intelligence, physiological genomics, and precision medicine.

Authors:  Anna Marie Williams; Yong Liu; Kevin R Regner; Fabrice Jotterand; Pengyuan Liu; Mingyu Liang
Journal:  Physiol Genomics       Date:  2018-01-26       Impact factor: 3.107

Review 4.  Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease.

Authors:  Helen C Looker; Michael Mauer; Robert G Nelson
Journal:  Adv Chronic Kidney Dis       Date:  2018-03       Impact factor: 3.620

5.  Downregulation of miR-17 suppresses TGF-β1-mediated renal fibrosis through targeting Smad7.

Authors:  Haixia Fu; Debo Chu; Xiuli Geng
Journal:  Mol Cell Biochem       Date:  2021-04-02       Impact factor: 3.396

6.  miR-125b Disrupts Mitochondrial Dynamics via Targeting Mitofusin 1 in Cisplatin-Induced Acute Kidney Injury.

Authors:  Yue Zhao; Yue Lang; Mingchao Zhang; Shaoshan Liang; Xiaodong Zhu; Zhihong Liu
Journal:  Kidney Dis (Basel)       Date:  2021-11-30

7.  MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension.

Authors:  Yong Liu; Kristie Usa; Feng Wang; Pengyuan Liu; Aron M Geurts; Junhui Li; Anna Marie Williams; Kevin R Regner; Yiwei Kong; Han Liu; Jing Nie; Mingyu Liang
Journal:  J Am Soc Nephrol       Date:  2018-07-26       Impact factor: 10.121

8.  MiR-192-5p in the Kidney Protects Against the Development of Hypertension.

Authors:  Maria Angeles Baker; Feng Wang; Yong Liu; Alison J Kriegel; Aron M Geurts; Kristie Usa; Hong Xue; Dandan Wang; Yiwei Kong; Mingyu Liang
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

9.  miR-146b-5p has a sex-specific role in renal and cardiac pathology in a rat model of chronic kidney disease.

Authors:  Mark R Paterson; Aron M Geurts; Alison J Kriegel
Journal:  Kidney Int       Date:  2019-08-16       Impact factor: 10.612

Review 10.  The Non-Coding RNA Landscape in IgA Nephropathy-Where Are We in 2021?

Authors:  Izabella Z A Pawluczyk; Haresh Selvaskandan; Jonathan Barratt
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.